Browsing by author "Rodríguez García, Manuel"

Análisis de un programa de vigilancia para el diagnóstico precoz de carcinoma hepatocelular en pacientes con cirrosis hepática

Mancebo Mata, Alejo (2017-03-27)

Beneficios individuales y colectivos del tratamiento del virus de la hepatitis C en pacientes con fibrosis hepática avanzada y cirrosis

Fraile López, Miguel (2021-07-02)

Características de las infecciones bacterianas en los pacientes con cirrosis hepática

Vivas Alegre, Santiago (2000-02-10)

Clinical characteristics of hepatocellular carcinoma in Spain. Comparison with the 2008-2009 period and analysis of the causes of diagnosis out of screening programs. Analysis of 686 cases in 73 centers

Rodríguez de Lope, Carlos; Reig, María; Matilla, Ana; Rodríguez García, Manuel

; Varela Calvo, María

(2017)

Desarrollo de un modelo predictivo de la aparición de carcinoma hepatocelular en pacientes con cirrosis hepática

Fernández Velázquez, María Rosario (2002-07-05)

Efficacy and safety of entecavir in clinical practice in treatment-naive Caucasian chronic hepatitis B patients

Buti Ferret, María Asunción; Morillas Cunill, Rosa María; Prieto Castillo, Martín; Diago Madrid, Moisés; Pérez Martínez, Juan; Solá Lamoglia, Ricard; Bonet Vidal, María Lucía; Palau Canós, Antonio; Testillano Tarrero, Milagros; García-Samaniego Rey, Francisco Javier; Rodríguez García, Manuel

; ORIENTE Study Group (2012)

Evaluation of cardiovascular events in patients with hepatocellular carcinoma treated with sorafenib in the clinical practice. The Cardio-sor study

Carballo Folgoso, Lorena; Ávarez Velasco, Rut; Lorca Gutiérrez, Rebeca

; Castaño García, Andrés; Cuevas, Javier; Luisa González Diéguez, María Luisa; Martin, Maria; Álvarez Navascués, Carmen; Cadahía Rodrigo, Valle; Morís de la Tassa, César

; Rodríguez García, Manuel

; Varela Calvo, María

(2021)

Genetic contribution of endoplasmic reticulum aminopeptidase 1 polymorphisms to liver fibrosis progression in patients with HCV infection

Vidal Castiñeira, José Ramón

; López Vázquez, Antonio

; Díaz Bulnes, Paula; Díaz Coto, Susana; Márquez Kisinousky, L.; Martínez Borra, Jesús

; Álvarez Navascués, Carmen; Sanz Cameno, Paloma; Vega, J. de la; Astudillo González, María Aurora

; Rodríguez García, Manuel

; López Larrea, Carlos

(2020)

Impact of alcohol abstinence on the risk of hepatocellular carcinoma in patients with alcohol-related liver cirrhosis

Rodríguez García, Manuel

; González Diéguez, María Luisa; Varela, M.; Cadahía Rodrigo, Valle; Andrés Vizan, Sara María

; Mesa, A.; Castaño García, Andrés; Álvarez Navascués, Carmen (2021)

Incidence and risk factors associated with hepatocellular carcinoma surveillance failure

Mancebo Mata, Alejo; Varela Calvo, María

; González Diéguez, María Luisa; Álvarez Navascués, Carmen; Cadahía Rodrigo, Valle; Mesa Álvarez, Alicia; Rodrigo Sáez, Luis Ricardo

; Rodríguez García, Manuel

(2018)

Liver expression of matrix metalloproteases and their inhibitors in hepatocellular carcinoma

Altadill Arregui, Antonio; Rodríguez García, Manuel

; González, Luis O.; Junquera, Sara; Corte, María Daniela; González Diéguez, María Luisa; Linares Rodríguez, Antonio; Barbón, Esther; Fresno Forcelledo, Manuel Florentino

; Rodrigo Sáez, Luis Ricardo

; Vizoso Piñeiro, Francisco José

(2009)

Long-term outcome in Caucasian patients with chronic hepatitis B virus infection after HBsAg seroclearance

Lauret Braña, María Eugenia; González Diéguez, María Luisa; Rodríguez Pérez, Mercedes

; González, Marta; Melón García, Santiago

; Rodrigo Sáez, Luis Ricardo

; Rodríguez García, Manuel

(2014)

Low applicability of the ''six-and-twelve score” in hepatocellular carcinoma treated with drug-eluting bead transarterial chemoembolization

Pipa Muñiz, M.; Castaño García, A.; Sanmartino, S.; Mesa, A.; Álvarez Navascués, Carmen; González Diéguez, M. L.; Cadahía Rodrigo, V.; Piscoya Díaz, M. E.; Costilla García, Serafín Marcos

; Rodríguez García, Manuel

; Varela Calvo, María

(2022)

Modificaciones en las características de los ingresos hospitalarios por cirrosis descompensada en la era de los antivirales de acción directa frente al virus de la hepatitis C

Fraile López, Miguel; Franco, Lissa; Álvarez Navascués, Carmen; Varela Calvo, María

; Cadahía Rodrigo, Valle; Torner, María; Gómez Outomuro, A.; González Diéguez, María Luisa; Rodríguez García, Manuel

(2020)

Mutaciones del gen HFE en la enfermedad hepática crónica

Lauret Braña, María Eugenia (2003-06-13)

New therapies: Calcimimetics, phosphate binders and vitamin D receptor activators

Cannata Andía, Jorge Benito

; Rodríguez García, Manuel

; Román García, Pablo

; Tuñón Le Poultel, Diego; López Hernández, Francisco José; Rodríguez Puyol, Diego (2010)

Prevalencia y significado del anticuerpo frente al virus C en hepatitis víricas agudas y crónicas

Rodríguez García, Manuel

(1991)

Progression of vascular calcifications is associated with greater bone loss and increased bone fractures

Naves Díaz, Manuel Luis; Rodríguez García, Manuel

; Díaz López, José Bernardino

; Gómez Alonso, Carlos

; Cannata Andía, Jorge Benito

(2008)

Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection

López Vázquez, Antonio

; Rodrigo Sáez, Luis Ricardo

; Martínez Borra, Jesús

; Pérez Álvarez, Ramón

; Rodríguez García, Manuel

; Fernández Morera, Juan Luis

; Fuentes Álvarez, Dolores

; Rodríguez Rodero, Sandra

; González Rodríguez, Segundo

; López Larrea, Carlos

(2005)

Quality of life in cirrhotic patients and liver transplant recipients

Pantiga Alonso, Carmen; López Álvarez, Laudino

; Pérez Álvarez, Marino

; Rodríguez García, Manuel

; Linares Rodríguez, Antonio; Diéguez, Luisa G.; Alonso, Pilar; Hernández Mejía, Radhamés

; Rodrigo Sáez, Luis Ricardo

(Colegio Oficial de Psicólogos del Principado de Asturias, 2005)

Browsing by author "Rodríguez García, Manuel"

Análisis de un programa de vigilancia para el diagnóstico precoz de carcinoma hepatocelular en pacientes con cirrosis hepática ﻿

Beneficios individuales y colectivos del tratamiento del virus de la hepatitis C en pacientes con fibrosis hepática avanzada y cirrosis ﻿

Características de las infecciones bacterianas en los pacientes con cirrosis hepática ﻿

Clinical characteristics of hepatocellular carcinoma in Spain. Comparison with the 2008-2009 period and analysis of the causes of diagnosis out of screening programs. Analysis of 686 cases in 73 centers ﻿

Desarrollo de un modelo predictivo de la aparición de carcinoma hepatocelular en pacientes con cirrosis hepática ﻿

Efficacy and safety of entecavir in clinical practice in treatment-naive Caucasian chronic hepatitis B patients ﻿

Evaluation of cardiovascular events in patients with hepatocellular carcinoma treated with sorafenib in the clinical practice. The Cardio-sor study ﻿

Genetic contribution of endoplasmic reticulum aminopeptidase 1 polymorphisms to liver fibrosis progression in patients with HCV infection ﻿

Impact of alcohol abstinence on the risk of hepatocellular carcinoma in patients with alcohol-related liver cirrhosis ﻿

Incidence and risk factors associated with hepatocellular carcinoma surveillance failure ﻿

Liver expression of matrix metalloproteases and their inhibitors in hepatocellular carcinoma ﻿

Long-term outcome in Caucasian patients with chronic hepatitis B virus infection after HBsAg seroclearance ﻿

Low applicability of the ''six-and-twelve score” in hepatocellular carcinoma treated with drug-eluting bead transarterial chemoembolization ﻿

Modificaciones en las características de los ingresos hospitalarios por cirrosis descompensada en la era de los antivirales de acción directa frente al virus de la hepatitis C ﻿

Mutaciones del gen HFE en la enfermedad hepática crónica ﻿

New therapies: Calcimimetics, phosphate binders and vitamin D receptor activators ﻿

Prevalencia y significado del anticuerpo frente al virus C en hepatitis víricas agudas y crónicas ﻿

Progression of vascular calcifications is associated with greater bone loss and increased bone fractures ﻿

Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection ﻿

Quality of life in cirrhotic patients and liver transplant recipients ﻿

Análisis de un programa de vigilancia para el diagnóstico precoz de carcinoma hepatocelular en pacientes con cirrosis hepática

Beneficios individuales y colectivos del tratamiento del virus de la hepatitis C en pacientes con fibrosis hepática avanzada y cirrosis

Características de las infecciones bacterianas en los pacientes con cirrosis hepática

Clinical characteristics of hepatocellular carcinoma in Spain. Comparison with the 2008-2009 period and analysis of the causes of diagnosis out of screening programs. Analysis of 686 cases in 73 centers

Desarrollo de un modelo predictivo de la aparición de carcinoma hepatocelular en pacientes con cirrosis hepática

Efficacy and safety of entecavir in clinical practice in treatment-naive Caucasian chronic hepatitis B patients

Evaluation of cardiovascular events in patients with hepatocellular carcinoma treated with sorafenib in the clinical practice. The Cardio-sor study

Genetic contribution of endoplasmic reticulum aminopeptidase 1 polymorphisms to liver fibrosis progression in patients with HCV infection

Impact of alcohol abstinence on the risk of hepatocellular carcinoma in patients with alcohol-related liver cirrhosis

Incidence and risk factors associated with hepatocellular carcinoma surveillance failure

Liver expression of matrix metalloproteases and their inhibitors in hepatocellular carcinoma

Long-term outcome in Caucasian patients with chronic hepatitis B virus infection after HBsAg seroclearance

Low applicability of the ''six-and-twelve score” in hepatocellular carcinoma treated with drug-eluting bead transarterial chemoembolization

Modificaciones en las características de los ingresos hospitalarios por cirrosis descompensada en la era de los antivirales de acción directa frente al virus de la hepatitis C

Mutaciones del gen HFE en la enfermedad hepática crónica

New therapies: Calcimimetics, phosphate binders and vitamin D receptor activators

Prevalencia y significado del anticuerpo frente al virus C en hepatitis víricas agudas y crónicas

Progression of vascular calcifications is associated with greater bone loss and increased bone fractures

Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection

Quality of life in cirrhotic patients and liver transplant recipients